These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35525989)

  • 1. Key measurement concepts and appropriate clinical outcome assessments in pediatric achondroplasia clinical trials.
    Aldhouse NVJ; Kitchen H; Johnson C; Marshall C; Pegram H; Pease S; Collins S; Baker CL; Beaverson K; Crews C; Massey J; Wyrwich KW
    Orphanet J Rare Dis; 2022 May; 17(1):182. PubMed ID: 35525989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-cultural selection and validation of instruments to assess patient-reported outcomes in children and adolescents with achondroplasia.
    Bloemeke J; Sommer R; Witt S; Bullinger M; Nordon C; Badia FJ; González FL; Leiva-Gea A; Delgado Rufino FB; Mayoral-Cleries F; Romero-Sanchiz P; Clamagirand Saiz V; Nogueira-Arjona R; Mohnike K; Quitmann J
    Qual Life Res; 2019 Sep; 28(9):2553-2563. PubMed ID: 31093848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing asthma symptoms in children: qualitative research supporting the development of the Pediatric Asthma Diary-Child (PAD-C) and Pediatric Asthma Diary-Observer (PAD-O).
    Bradley H; Trennery C; Jones AM; Lydon A; White F; Williams-Hall R; Arbuckle R; Tomaszewski E; Shih VH; Haughney J; Eisen A; Winders T; Coons SJ; Eremenco S;
    J Patient Rep Outcomes; 2023 Oct; 7(1):104. PubMed ID: 37863864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing physical symptoms, daily functioning, and well-being in children with achondroplasia.
    Pfeiffer KM; Brod M; Smith A; Gianettoni J; Viuff D; Ota S; Charlton RW
    Am J Med Genet A; 2021 Jan; 185(1):33-45. PubMed ID: 33084192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in pre-pubertal children with pediatric growth hormone deficiency: 12-month results from a phase 3 clinical trial of once-weekly somatrogon versus once-daily somatropin.
    Loftus J; Quitmann J; Valluri SR
    Curr Med Res Opin; 2024 Feb; 40(2):175-184. PubMed ID: 38053515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the impacts of having a child with achondroplasia on parent well-being.
    Pfeiffer KM; Brod M; Smith A; Gianettoni J; Viuff D; Ota S; Charlton RW
    Qual Life Res; 2021 Jan; 30(1):203-215. PubMed ID: 32803627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functioning and well-being in older children and adolescents with achondroplasia: A qualitative study.
    Pfeiffer KM; Brod M; Smith A; Viuff D; Ota S; Charlton RW
    Am J Med Genet A; 2022 Feb; 188(2):454-462. PubMed ID: 34643322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative research with patients and caregivers of patients with PIK3CA related overgrowth spectrum: content validity of clinical outcome assessments.
    Raymond K; Vallow S; Saucier C; Jackson K; White MK; Lovley A; D'Alessio D
    J Patient Rep Outcomes; 2022 Jul; 6(1):75. PubMed ID: 35829859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life, physical functioning, and psychosocial function among patients with achondroplasia
    Constantinides C; Landis SH; Jarrett J; Quinn J; Ireland PJ
    Disabil Rehabil; 2022 Oct; 44(21):6166-6178. PubMed ID: 34403286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Clinical Global Impression of Change (CGI-C) and a Caregiver Global Impression of Change (CaGI-C) measure for ambulant individuals with Duchenne muscular dystrophy.
    Staunton H; Trennery C; Arbuckle R; Guridi M; Zhuravleva E; Furlong P; Fischer R; Hall R
    Health Qual Life Outcomes; 2021 Jul; 19(1):184. PubMed ID: 34311756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing Angelman syndrome-specific clinician-reported and caregiver-reported measures to support holistic, patient-centered drug development.
    Connor-Ahmad S; Tjeertes J; Chladek M; Newton L; Symonds T; Clinch S; Vincenzi B; McDougall F
    Orphanet J Rare Dis; 2023 Jun; 18(1):156. PubMed ID: 37349793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ICF-CY-based approach to assessing self- and observer-reported functioning in young persons with achondroplasia - development of the pilot version of the Achondroplasia Personal Life Experience Scale (APLES).
    Sommer R; Blömeke J; Dabs M; Witt S; Bullinger M; Quitmann J
    Disabil Rehabil; 2017 Dec; 39(24):2499-2503. PubMed ID: 27636099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): defining and measuring functional impacts in pediatric patients.
    Leiro B; Phillips D; Duiker M; Harmatz P; Charles S
    Orphanet J Rare Dis; 2021 Dec; 16(1):500. PubMed ID: 34857033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A qualitative study of the impacts of having an infant or young child with achondroplasia on parent well-being.
    Pfeiffer KM; Brod M; Smith A; Viuff D; Ota S; Charlton RW
    Orphanet J Rare Dis; 2021 Aug; 16(1):351. PubMed ID: 34362417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric properties of the quality of life in short statured youth (QoLISSY) questionnaire within the course of growth hormone treatment.
    Bloemeke J; Silva N; Bullinger M; Witt S; Dörr HG; Quitmann J
    Health Qual Life Outcomes; 2019 Mar; 17(1):49. PubMed ID: 30885197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of six PROMIS pediatrics proxy-report item banks.
    Irwin DE; Gross HE; Stucky BD; Thissen D; DeWitt EM; Lai JS; Amtmann D; Khastou L; Varni JW; DeWalt DA
    Health Qual Life Outcomes; 2012 Feb; 10():22. PubMed ID: 22357192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parental perception of health-related quality of life in children and adolescents with short stature: literature review and introduction of the parent-reported QoLISSY instrument.
    Quitmann J; Rohenkohl A; Bullinger M; Chaplin JE; Herdman M; Sanz D; Mimoun E; Feigerlova E; DeBusk K; Power M; Wollmann H; Pleil A
    Pediatr Endocrinol Rev; 2013 Dec; 11(2):147-60. PubMed ID: 24575550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Conceptual Model of Angelman Syndrome and Review of Relevant Clinical Outcomes Assessments (COAs).
    Grieco JC; Romero B; Flood E; Cabo R; Visootsak J
    Patient; 2019 Feb; 12(1):97-112. PubMed ID: 29987743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quality of life in children, adolescents, and young adults with achondroplasia].
    Rohenkohl AC; Bullinger M; Quitmann J
    Orthopade; 2015 Mar; 44(3):212-8. PubMed ID: 25217045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of patient- and observer-reported outcome measures to assess COVID-19 signs and symptoms in children and adolescents.
    Romano C; Mayorga M; Ruiz-Guiñazú J; Trudel GC; Fehnel S; McQuarrie K; Chan EKH; Katz EG
    J Patient Rep Outcomes; 2023 Jan; 7(1):7. PubMed ID: 36701073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.